Skip to main content
Journal cover image

A new BEACON of hope for the treatment of inflammation? The endogenous metabolite itaconate as an alternative activator of the KEAP1-Nrf2 system.

Publication ,  Journal Article
Perico, L; Wyatt, CM; Benigni, A
Published in: Kidney Int
October 2018

Duke Scholars

Published In

Kidney Int

DOI

EISSN

1523-1755

Publication Date

October 2018

Volume

94

Issue

4

Start / End Page

646 / 649

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Succinates
  • NF-E2-Related Factor 2
  • Kelch-Like ECH-Associated Protein 1
  • Inflammation
  • Humans
  • Anti-Inflammatory Agents
  • Alkylation
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Perico, L., Wyatt, C. M., & Benigni, A. (2018). A new BEACON of hope for the treatment of inflammation? The endogenous metabolite itaconate as an alternative activator of the KEAP1-Nrf2 system. Kidney Int, 94(4), 646–649. https://doi.org/10.1016/j.kint.2018.07.018
Perico, Luca, Christina M. Wyatt, and Ariela Benigni. “A new BEACON of hope for the treatment of inflammation? The endogenous metabolite itaconate as an alternative activator of the KEAP1-Nrf2 system.Kidney Int 94, no. 4 (October 2018): 646–49. https://doi.org/10.1016/j.kint.2018.07.018.
Perico, Luca, et al. “A new BEACON of hope for the treatment of inflammation? The endogenous metabolite itaconate as an alternative activator of the KEAP1-Nrf2 system.Kidney Int, vol. 94, no. 4, Oct. 2018, pp. 646–49. Pubmed, doi:10.1016/j.kint.2018.07.018.
Journal cover image

Published In

Kidney Int

DOI

EISSN

1523-1755

Publication Date

October 2018

Volume

94

Issue

4

Start / End Page

646 / 649

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Succinates
  • NF-E2-Related Factor 2
  • Kelch-Like ECH-Associated Protein 1
  • Inflammation
  • Humans
  • Anti-Inflammatory Agents
  • Alkylation
  • 3202 Clinical sciences
  • 1103 Clinical Sciences